021-51111890
购物车（）
sales@molnova.cn
BCI-215
CAS No. 1245792-67-9
BCI-215 ( —— )
产品货号. M20710 CAS No. 1245792-67-9
BCI-215 causes selective cancer cell cytotoxicity in part through non-redox-mediated activation of MAPK signaling.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥1531 | 有现货 |
|
| 5MG | ￥2333 | 有现货 |
|
| 10MG | ￥3645 | 有现货 |
|
| 25MG | ￥6010 | 有现货 |
|
| 50MG | ￥7995 | 有现货 |
|
| 100MG | ￥11259 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称BCI-215
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述BCI-215 causes selective cancer cell cytotoxicity in part through non-redox-mediated activation of MAPK signaling.
-
产品描述BCI-215 causes selective cancer cell cytotoxicity in part through non-redox-mediated activation of MAPK signaling.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number1245792-67-9
-
分子量396.3
-
分子式C22H22BrNO
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESBrc1ccc2C(=O)\C(C(NC3CCCCC3)c2c1)=C\c1ccccc1
-
化学全称(E)-2-Benzylidene-5-bromo-3-cyclohexylamino-indan-1-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Kaltenmeier C T Vollmer L L Vernetti L A et al. A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity[J]. Journal of Pharmacology and Experimental Therapeutics 2017 361(1):39-50.
产品手册
关联产品
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
(2R)-1-(tert-butylam...
(2R)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol; but-2-enedioic acid is a chemical compound.
-
RET-IN-1
RET-IN-1 is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 552, has IC50s of 1 nM, 7 nM, and 101 nM for RET (WT), RET (V804M) , and RET (G810R), respectively .
